trending Market Intelligence /marketintelligence/en/news-insights/trending/VwwKZsuolKnEyvET4i4biA2 content esgSubNav
In This List

Valeant unit receives US FDA clearance for cataract surgery platform

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Valeant unit receives US FDA clearance for cataract surgery platform

The U.S. FDA cleared Bausch & Lomb's Stellaris Elite Vision Enhancement System.

The Valeant Pharmaceuticals International Inc. unit received 510(k) clearance for the system, which facilitates cataract surgery by allowing surgeons to further customize their machines.